Replies to post #106472 on Cytodyn Inc (CYDY)

[Evil Rabbit]

I hope the FDA gives an EUA just to quiet all the conspiracy theorists once and for all.

I’d guess 60/40 for approval, not a “long shot.”

Leronlimab is safe, we’re in a pandemic, and it works.

Next week we’ll know.

[daemon57]

I was contemplating whether I post this or not, but I noticed on another board that there actually is a company, Gammacore (ECOR) that's listed on the Nasdaq that popped when it received EAU from the FDA:

https://www.fda.gov/media/139967/download#:~:text=that%20the%20U.S.%20Food%20and,exacerbation%20of%20asthma%2Drelated%20dyspnea

It hit 5x but trended down to where it sits at at $2.27, last close.

IMHO, if we were to see the $25-$30 SP that NP was talking about, 100% we need to be on Nasdaq as IMO, it won't get that velocity here at the OTCBB exchange. We also need to get that PDUFA date which keep the trading in that range.

Best case scenario is that we list first (may not move the SP, but actually drop it some (there were a few scenarios that had stocks move from BB to NQ) THEN we get the EUA off the CD12 trial (as in my opinion FDA follows protocol and they will only give that designation of PH3) and we hear back on PDUFA date.

All, IMO.

GLTU/A.

[Learning53]

Help from an unexpected source.

So we're sending off M2M info to the UK, EU, IS, and beyond. ...And all those governments are "leak-proof" right...LOL. Strangely we might get more "buzz" from overseas than our own backyard. Don't be surprised if we get a new audience, especially if they're considering approval. The good 'ole boy system is alive and well everywhere...and when there's a buck, euro, pound, etc. to be made...

The shorts could be in for a rocky ride, one they won't see coming. ...And it might start Monday. Depends how fast that info went out. Somebody somewhere's going to, "Holy sh**, look at this...got to brief the boss, but first I'll give my broker a call..."

Delicious - it might even get some folks over here off their arses, as others attempt to snatch the existing supply(s) - otherwise they'll have covid-egg on their collective faces.

Smile

So shorts - when you finally catch your share of the covid, just remember why LL might not be available here...enjoy your remdesivir.

[All-Bidness]

I agree,
Where's the BP, where's the Big Media, waiting on results, it's been quiet since released.

Why hasn't the fact that we applied for EUA been PR'd?

Are the other countries a head fake.

Nader likes to talk a lot but I don't see a lot getting completed.

[3X Charm]

Dead on Saltz.
Pharma friends tell me EU, UK is a mirage for M2M, without FDA approval. Another red herring for NP to puff about with no results. The CYDY BOD is useless. They are supposed to protect shareholder interests. Where is the accountability? People give NP Kudos for submissions , but anyone can submit things. NP has been at CYDY for 8 plus years. What has actually completed/ finished 100%.?

Yes, I am actually looking for an answer to that and submitted is not the goal line.

[jimmy667]

Two things. One the CD12 S2C trial was predetermined to have interim analysis done at a predetermined milestone. That milestone is 195 enrolled participants. NOT 195 completing the 28 day treatment. One has to realize this. Why assume they have to complete the 28 days? Someone just wrongly guessed that was the case. A trial for a severe and critical illness where death/life is the primary endpoint can NEVER have a number of participants completing treatments because of the high chance of fatalities. They could have made the milestone 195 completing 28 days or death. They did not. The milestone is 195 participants enrolled. Period.